CMS Open Payments · Program Year 2024
CorMedix Inc.
CorMedix Inc. reported $120,248.72 across General Payments, Research, and Ownership to 1,060 physicians and teaching hospitals across 1,060 transactions.
- $120.2K Below-median payer
- All-tracks total
- 1,060 Above-median volume
- Transactions
- 1,060 Above-median reach
- Recipients
- #1134
- of 1,925 companies
CorMedix Inc. reported $120,248.72 across all CMS Open Payments tracks (General + Research + Ownership) to 1,060 physicians and teaching hospitals in Program Year 2024 - ranking #1134 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $120,248.72, averaging $113.44 per recipient.
How CorMedix Inc.'s $120.2K all-tracks total breaks down
CorMedix Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
21/100
Total payments
F
11/100
Transaction volume
F
18/100
Physician reach
F
18/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer cormedix-inc CorMedix Inc.
$120.2K · #1134/1,925 · 0.0% industry · PY2024
- TOT $120.2K
- RANK #1134
- SHARE 0.0%
- TXN 1,060
- RCP 1,060
- CAT 3
- GEN $120.2K
- TOP1 33.2%
- PY 2024
Volume peers
Nearest volume peer: Aurobindo Pharma USA, Inc. ($120.1K)
CorMedix Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for CorMedix Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For CorMedix Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $86.5K, accounting for 71.9% of this company's General Payments and 9 transactions.
General Payment Breakdown by Type
Across 3 types of general payments, CorMedix Inc.'s largest category was "Consulting Fee" at $86.5K - 71.9% of General Payments.
How CorMedix Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $86.5K | 9 | 71.9% |
| Food and Beverage | $30.7K | 1,045 | 25.6% |
| Travel and Lodging | $3.0K | 6 | 2.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $90,482.60 (75.2%) of $120,248.72 in this company's General Payments records across 739 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for CorMedix Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Alan William Dunton
$39,873.32 across 11 reported transactions
- 2
Janet Connor
$39,000.00 across 2 reported transactions
- 3
Anil K Agarwal
$10,350.00 across 1 reported transactions
- 4
Bruce Reidenberg
$812.50 across 3 reported transactions
- 5
Payal Patel
$446.78 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
CorMedix Inc. ranks #1134 of 1,925 by total payments (bottom 41% by spend) but is notably more concentrated than that alone would suggest -- #711 of 1,838 by HHI (top 39% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Medunik USA Inc. : $2.1K total payments, HHI 2256
- Advanced Bionics, LLC : $64.6K total payments, HHI 2255
- Activ Surgical, Inc. : $48.3K total payments, HHI 2249
- Haemonetics Corporation : $1.2M total payments, HHI 2247
- Actelion Pharmaceuticals, Ltd : $103.2K total payments, HHI 2241
- Catalyst OrthoScience : $619.0K total payments, HHI 2229
- CorMedix Inc. (this company) : $120.2K total payments, HHI 2228
- Peter Brasseler Holdings, LLC : $2.8M total payments, HHI 2223
- Paragonix Technologies, Inc. : $2.6M total payments, HHI 2220
- Freudenberg Medical, LLC : $88.80 total payments, HHI 2216
- Servier BioInnovation : $2.1K total payments, HHI 2211
- Endovascular Engineering Inc. : $44.3K total payments, HHI 2208
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as CorMedix Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about CorMedix Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with CorMedix Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)
NuMED for Children, LLC
Shalby Advanced Technologies, Inc.
Ikon Spine LLC
InSightec,Inc
Put this to use
CorMedix Inc. ranks #1134 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just CorMedix Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.